Is Spero Therapeutics, Inc. overvalued?

Spero Therapeutics, Inc. (SPRO) — key valuation metrics and fundamentals.

No verdict

Price

$1.23

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$71.2M

Dividend yield

4.9%

Return on equity

35.6%

Sector

Healthcare

Fair value compares SPRO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks